StockData
Lexicon Pharmaceuticals, Inc. logo

Lexicon Pharmaceuticals, Inc. (LXRX) stock

LXRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3087% above fair value
$1.78+0.03 (+1.71%)

Close on Nov 17, 2026Market cap $792.02MP/E –Yield –

Lexicon Pharmaceuticals EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Lexicon Pharmaceuticals's EV/EBITDA was 14.2× on Oct 29, 2021, against 1.6× a year earlier.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2021Oct 29, 202114.2×+11.2
2020Oct 30, 20203.0×+0.8
2019Dec 31, 20192.2×−458.9
2016Apr 29, 2016461.1×–

More Lexicon Pharmaceuticals figures

See a number that looks wrong?